Brief: Sensei Biotherapeutics Reports Q1 2023 Financial Results And Recent Business Highlights
09/05/2023 13:33
May 9 (Reuters) - Sensei Biotherapeutics Inc SNSE.O :
* SENSEI BIOTHERAPEUTICS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* SENSEI BIOTHERAPEUTICS INC - STRONG BALANCE SHEET WITH
CASH
RUNWAY INTO SECOND HALF OF 2025
* SENSEI BIOTHERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES WERE $95.5 MILLION AS OF MARCH 31, 2023
* SENSEI BIOTHERAPEUTICS INC - QTRLY NET LOSS PER SHARE
$0.33
Source text for Eikon: ID:nGNX9w3MnL
Further company coverage: SNSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Faeth Therapeutics,
See all newsBrief: Sensei Biotherapeutics Announces Name Change To Faeth Therapeutics
Brief: Sensei Biotherapeutics Doses First Patient In Phase 1B/2 Trial Of Piktor In Hr+/Her2- Advanced Breast Cancer
Brief: Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)